USSTOCK.TODAY
Market Closed
Log in Sign up

Nurix Therapeutics reports surge in Q3 revenue to $673.1 million

Investing.com ·

NRIX
NRIX Nurix Therapeutics Inc
$22.12 -0.18%
View chart & analysis →
  1. 1Nurix Therapeutics recorded $673.1 million in revenue for the third quarter of fiscal year 2026.
  2. 2Nurix Therapeutics recorded adjusted earnings per share of $4.73 for the third quarter of fiscal year 2026.
  3. 3Nurix Therapeutics shares fell 2% in after-hours trading following the earnings announcement.

So what's the key point?

Nurix Therapeutics recorded $673.1 million in revenue for the third quarter. The stock price fell 2% in after-hours trading after the earnings announcement.

Source Investing.com · View original ↗

Related 3-line summaries

Braemar Hotels Resorts Agrees to Sell Four Seasons Resort Scottsdale for $372 Million CRE Daily · 2h ago1800 Avenue of the Stars Campus Secures $550 Million Refinancing CRE Daily · 2h agoC3.ai shares up 10% following Northland price target hike TIKR · 2h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news